Tuxin Pharmaceutical's (301089.SZ) subsidiary receives approval for the marketing of Safinamide Mesylate API

Zhitong Finance APP News, Tuoxin Pharmaceutical (301089.SZ) announced that recently, the active pharmaceutical ingredient safinamide mesylate of its wholly-owned subsidiary Xinxiang Pharmaceutical Co., Ltd. obtained the "Chemical Active Pharmaceutical Ingredient Marketing Application Approval Notification" issued by the National Medical Products Administration.